IP Library › Assignment 032161/0475
Patent Assignment
Reel/Frame 032161/0475

Termination and Release of Security Interest in Patents (First Lien)

Recorded: 2014-02-04 Pages: 6
Assignor
Assignees
ALKERMES, INC.
852 WINTER STREET, WALTHAM, MASSACHUSETTS, 02451
ALKERMES PHARMA IRELAND LIMITED
MONSKLAND, ATHLONE CO. WESTMEATH, IRELAND
Covered Properties (7)
Nanoparticulate aripiprazole formulations
Application: 11/520,058 →
Publication: US US20070148100A1
Methods for Administering Aripiprazole
Patent: 8,759,351 →
Application: 13/648,544 →
Publication: US US20130090343A1
Methods for Administering Active Agents to CYP3A4 Sensitive Patients
Application: 12/241,404 →
Publication: US US20090022823A1
Methods for Administering Aripiprazole
Patent: 8,338,427 →
Application: 12/251,656 →
Publication: US US20090143403A1
Methods for Administering Aripiprazole
Patent: 8,338,428 →
Application: 13/420,822 →
Publication: US US20120289516A1
Aripiprazole, Olanzapine and Haloperidol Pamoate Salts
Patent: 6,987,111 →
Application: 10/635,232 →
Publication: US US20050032836A1
Method of Preparing Sustained Release Microparticles
Patent: 7,658,998 →
Application: 10/762,220 →
Publication: US US20040247870A1
Related Assignments (13)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Oct 31, 2007
From: ALKERMES CONTROLLED THERAPEUTICS, II
To: ALKERMES, INC.
Reel/Frame 020035/0827 →
Patent Security Agreement (First Lien) Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Patent Security Agreement (Second Lien) Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Asset Transfer Agreement Oct 10, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029108/0426 →
Change of Name Oct 10, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029104/0071 →
Release by Secured Party (Second Lien) Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Assignment of Assignor's Interest Apr 19, 2013
From: ALKERMES, INC.
To: OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 030253/0038 →
Assignment of Assignor's Interest May 5, 2014
From: ALKERMES, INC.
To: OTSUKA PHARMACEUTICALS CO.,LTD
Reel/Frame 032819/0401 →
Assignment of Assignor's Interest May 5, 2014
From: BROWN, JOSIAH
To: ALKERMES CONTROLLED THERAPEUTICS, II
Reel/Frame 032819/0386 →
Assignment of Assignor's Interest May 23, 2014
From: ALKERMES, INC.
To: OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 032959/0432 →
Assignment of Assignor's Interest Jul 8, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 033264/0140 →
Assignment of Assignor's Interest Jul 29, 2015
From: ALKERMES, INC.
To: OTSUKA PHARMACEUTICAL CO., LTD
Reel/Frame 036210/0341 →
Release of Patent Security Agreement (First Lien) Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 069771/0548 →